Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 7
2021 10
2022 8
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Intermittent Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment Maintains High Level of Viral Suppression in Virally Suppressed People Living with HIV.
Sellem B, Abdi B, Lê M, Tubiana R, Valantin MA, Seang S, Schneider L, Fayçal A, Peytavin G, Soulié C, Marcelin AG, Katlama C, Pourcher V, Palich R. Sellem B, et al. Among authors: abdi b. J Pers Med. 2023 Mar 27;13(4):583. doi: 10.3390/jpm13040583. J Pers Med. 2023. PMID: 37108969 Free PMC article.
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance.
Lambert-Niclot S, Abdi B, Bellet J, Fofana D, De Truchis P, Amat K, Alvarez JC, Surgers L, Allavena C, Zaegell-Faucher O, Morlat P, Palich R, Gibowski S, Costagliola D, Girard PM, Landman R, Assoumou L, Morand-Joubert L; ANRS 170 QUATUOR study group. Lambert-Niclot S, et al. Among authors: abdi b. J Antimicrob Chemother. 2023 Jun 1;78(6):1510-1521. doi: 10.1093/jac/dkad119. J Antimicrob Chemother. 2023. PMID: 37104815
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study.
Schramm B, Temfack E, Descamps D, Nicholas S, Peytavin G, Bitilinyu-Bangoh JE, Storto A, Lê MP, Abdi B, Ousley J, Kalua T, Calvez V, Jahn A, Marcelin AG, Szumilin E. Schramm B, et al. Among authors: abdi b. Lancet HIV. 2022 Aug;9(8):e544-e553. doi: 10.1016/S2352-3018(22)00136-9. Lancet HIV. 2022. PMID: 35905753 Free article.
High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients.
Abdi B, Ndoadoumgue AL, Djebara S, Zafilaza K, Palich R, Marot S, Schneider L, Wirden M, Seang S, Dudoit Y, Teyssou E, Tubiana R, Soulie C, Valantin MA, Katlama C, Calvez V, Assoumou L, Marcelin AG, Pourcher V. Abdi B, et al. J Infect. 2022 Aug;85(2):e33-e36. doi: 10.1016/j.jinf.2022.05.036. Epub 2022 Jun 2. J Infect. 2022. PMID: 35662666 Free PMC article. No abstract available.
29 results